$1.110
+0.042 (+3.74%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
SNOA 相似圖表分析預測
Alphio's SNOA stock price prediction model matches the current Sonoma Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.13 (+1.40%). The 1-week path is $1.14 (+2.41%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Sonoma Pharmaceuticals Inc 股票嗎?
Sonoma Pharmaceuticals Inc (SNOA) appears to be a good buy right now due to its recent FDA clearance for the Microdacyn Wound Solution, which is expected to enhance market competitiveness. The stock is currently priced at $1.11, significantly below its 52-week high of $3.95, indicating potential for upside. Additionally, the company reported a 48.3% year-over-year revenue increase in Q4 2026, reaching $5.56 million, which reflects a strong recovery trend. However, a key risk is the forward P/E ratio of 46.08, suggesting that the stock may be overvalued relative to its earnings potential.
SNOA 股價於 Friday 收在 $1.11,此前上漲 +3.74%
Sonoma Pharmaceuticals Inc (SNOA) last closed at $1.11, gaining +3.74%. These facts feed the 1-day and 1-week SNOA price prediction above.
分析師一致預期
Sonoma Pharmaceuticals Inc(SNOA):買進 2、持有 0、賣出 0。展望:Strong Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
預測驅動因素
Sonoma Pharmaceuticals Inc(SNOA)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似圖表形態
近期走勢與 SNOA 最接近的股票,依相似度排序。
SNOA 季節性分析
Historically the probability of a positive November return for SNOA is 43.18%. July offers the highest probability of a positive month at 66.67%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
SNOA 十年價格預測
| 月份 | 最低價 | 平均價 | 最高價 | 潛在報酬率 |
|---|---|---|---|---|
| Nov 2026 | $3.30 | $3.86 | $4.03 | +248.19% |
| Dec 2026 | $3.78 | $4.08 | $4.90 | +267.80% |
2026 年,Sonoma Pharmaceuticals Inc(SNOA)預計區間為 $3.30 至 $4.90。
Sonoma Pharmaceuticals Inc 2026 年月度預測
2026 年 Nov,Sonoma Pharmaceuticals Inc 預計均價 $3.86,最低 $3.30,最高 $4.03。
2026 年 Dec,Sonoma Pharmaceuticals Inc 預計均價 $4.08,最低 $3.78,最高 $4.90。
相關文章
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。